[go: up one dir, main page]

ZA200410410B - New etonogestrel esters. - Google Patents

New etonogestrel esters.

Info

Publication number
ZA200410410B
ZA200410410B ZA200410410A ZA200410410A ZA200410410B ZA 200410410 B ZA200410410 B ZA 200410410B ZA 200410410 A ZA200410410 A ZA 200410410A ZA 200410410 A ZA200410410 A ZA 200410410A ZA 200410410 B ZA200410410 B ZA 200410410B
Authority
ZA
South Africa
Prior art keywords
new
etonogestrel esters
esters
new etonogestrel
etonogestrel
Prior art date
Application number
ZA200410410A
Other languages
English (en)
Inventor
Henrik De Nijs
Dirk Leysen
Hendrikus Adrianus Anton Voort
Arij Jan Grootenhuis
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA200410410B publication Critical patent/ZA200410410B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200410410A 2002-05-30 2004-12-23 New etonogestrel esters. ZA200410410B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02077119 2002-05-30

Publications (1)

Publication Number Publication Date
ZA200410410B true ZA200410410B (en) 2006-02-22

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200410410A ZA200410410B (en) 2002-05-30 2004-12-23 New etonogestrel esters.

Country Status (31)

Country Link
US (1) US7323454B2 (xx)
EP (1) EP1513861B1 (xx)
JP (1) JP4716726B2 (xx)
KR (1) KR20050009723A (xx)
CN (2) CN101100480A (xx)
AR (1) AR040130A1 (xx)
AT (1) ATE349458T1 (xx)
AU (1) AU2003238081B2 (xx)
BR (1) BR0311254A (xx)
CA (1) CA2487722C (xx)
CO (1) CO5631449A2 (xx)
DE (1) DE60310714T2 (xx)
DK (1) DK1513861T3 (xx)
ES (1) ES2277085T3 (xx)
HK (1) HK1072609A1 (xx)
HR (1) HRP20041101A2 (xx)
IL (1) IL165087A0 (xx)
IS (1) IS2421B (xx)
MX (1) MXPA04011797A (xx)
NO (1) NO20044898L (xx)
NZ (1) NZ536619A (xx)
PE (1) PE20040068A1 (xx)
PL (1) PL373855A1 (xx)
PT (1) PT1513861E (xx)
RS (1) RS97604A (xx)
RU (1) RU2325910C2 (xx)
SI (1) SI1513861T1 (xx)
TW (1) TW200403065A (xx)
UA (1) UA80126C2 (xx)
WO (1) WO2003102012A2 (xx)
ZA (1) ZA200410410B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
EP1909973B1 (en) 2005-07-15 2018-08-22 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
AU2007243268B2 (en) 2006-04-26 2013-06-13 Micell Technologies, Inc. Coatings containing multiple drugs
US9737642B2 (en) 2007-01-08 2017-08-22 Micell Technologies, Inc. Stents having biodegradable layers
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
EP2271294B1 (en) 2008-04-17 2018-03-28 Micell Technologies, Inc. Stents having bioabsorbable layers
WO2011009096A1 (en) 2009-07-16 2011-01-20 Micell Technologies, Inc. Drug delivery medical device
US9486431B2 (en) 2008-07-17 2016-11-08 Micell Technologies, Inc. Drug delivery medical device
CA2756386C (en) 2009-03-23 2019-01-15 Micell Technologies, Inc. Drug delivery medical device
US9981072B2 (en) 2009-04-01 2018-05-29 Micell Technologies, Inc. Coated stents
WO2010121187A2 (en) 2009-04-17 2010-10-21 Micell Techologies, Inc. Stents having controlled elution
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
CA2797110C (en) 2010-04-22 2020-07-21 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
CA2805631C (en) 2010-07-16 2018-07-31 Micell Technologies, Inc. Drug delivery medical device
WO2013012689A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
CN110269959A (zh) 2013-03-12 2019-09-24 脉胜医疗技术公司 可生物吸收的生物医学植入物
JP2016519965A (ja) 2013-05-15 2016-07-11 マイセル・テクノロジーズ，インコーポレイテッド 生体吸収性バイオメディカルインプラント
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
GB8313921D0 (en) * 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
CN1135716A (zh) * 1993-12-27 1996-11-13 阿克佐诺贝尔公司 经皮吸收的药用制剂
JPH11509222A (ja) * 1995-07-17 1999-08-17 シェリング アクチェンゲゼルシャフト １３−エチル−１７β−ヒドロキシ−１１−メチレン−１８，１９−ジノル−１７α−プレグン−４−エン−２０−イン−３−オンのエステルを含む経皮投与のための剤
DE19613698A1 (de) 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
PT1087986E (pt) 1998-06-19 2002-08-30 Akzo Nobel Nv Undecanoato de 7alfa-metil-19-nortestosterona com actividade androgenica
WO1999067270A1 (en) 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
US6180682B1 (en) 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Also Published As

Publication number Publication date
JP2005532350A (ja) 2005-10-27
US7323454B2 (en) 2008-01-29
WO2003102012A2 (en) 2003-12-11
KR20050009723A (ko) 2005-01-25
RU2004138807A (ru) 2005-05-27
EP1513861A2 (en) 2005-03-16
PE20040068A1 (es) 2004-02-18
MXPA04011797A (es) 2005-03-31
CO5631449A2 (es) 2006-04-28
PL373855A1 (en) 2005-09-19
JP4716726B2 (ja) 2011-07-06
CA2487722C (en) 2011-07-19
DE60310714T2 (de) 2007-10-11
CA2487722A1 (en) 2003-12-11
DK1513861T3 (da) 2007-04-10
EP1513861B1 (en) 2006-12-27
ATE349458T1 (de) 2007-01-15
TW200403065A (en) 2004-03-01
DE60310714D1 (de) 2007-02-08
SI1513861T1 (sl) 2007-06-30
HK1072609A1 (en) 2005-09-02
IS2421B (is) 2008-10-15
IL165087A0 (en) 2005-12-18
RS97604A (xx) 2006-10-27
BR0311254A (pt) 2005-03-15
UA80126C2 (en) 2007-08-27
CN101100480A (zh) 2008-01-09
AR040130A1 (es) 2005-03-16
WO2003102012A3 (en) 2004-04-22
US20050222113A1 (en) 2005-10-06
ES2277085T3 (es) 2007-07-01
AU2003238081A1 (en) 2003-12-19
NO20044898L (no) 2005-02-25
RU2325910C2 (ru) 2008-06-10
WO2003102012A9 (en) 2005-01-13
CN1314701C (zh) 2007-05-09
CN1692122A (zh) 2005-11-02
AU2003238081B2 (en) 2008-09-18
IS7528A (is) 2004-11-15
HRP20041101A2 (en) 2004-12-31
NZ536619A (en) 2007-09-28
PT1513861E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
MX247604B (es) Esteres de astaxantina.
ZA200410410B (en) New etonogestrel esters.
EP1545809A4 (en) drop forging
GB2400797B (en) Shelving
ZA200408787B (en) Pharmaceutical combination.
GB0202011D0 (en) The Fucker
GB0218515D0 (en) S.d.s.
EG23241A (en) Beshob.
GB0215256D0 (en) I.t
ZA200408169B (en) Imidazolinylmethyl aralkylsulfonamides.
MXPA02001688A (es) Marco facil.
MXPA02003350A (es) Calentador-tanque-termo-solar.
GB0212492D0 (en) D.I.Y. workvest
PL113111U1 (en) Shelving
ZA200206020B (en) Easy turn.
GB0227756D0 (en) P.H. tablet
GB0203705D0 (en) The equichute
GB0218474D0 (en) The Quitter
GB0213243D0 (en) The Unidriver
GB0202712D0 (en) The aquacycle
GB0214859D0 (en) The unicrutch
GB0228026D0 (en) The tippal
GB0203758D0 (en) The hitchey
GB0219558D0 (en) The waterball
GB0219446D0 (en) The riddlemaster